Cannabis rescheduling is being sold to the public as reform. It isn’t. It’s the same authoritarian control that’s governed this plant since 1970, just with a corporate facelift layered atop the original skull.
In 1970, Congress built the Controlled Substances Act and dropped cannabis into Schedule I, the same tier as heroin, reserved for drugs with “no currently accepted medical use” and a “high potential for abuse.” They mandated the Shafer Commission as part of the same law, got its 1972 answer that cannabis didn’t belong in Schedule I, and buried it. The classification was never science based. It was a political tool, and everyone who’s built on top of it since has known that.
You can’t fix 50 years of policy built on a lie by rearranging its address. Schedule I to Schedule III isn’t a repeal. It’s the same rotten foundation, permitted for one more floor.
The record needs setting straight, because it’s messier than “Biden started it, Trump’s finishing it for a headline.”
In April 2026, the Drug Enforcement Administration didn’t just fast-track paperwork. It issued a final order moving two narrow categories of cannabis into Schedule III: FDA-approved drug products and marijuana sold under a state medical license. That’s it. Recreational cannabis, in every adult-use state, stayed exactly where it’s been for over 50 years: Schedule I, right alongside heroin.
The financial effect was immediate. Section 280E of the tax code (which bars Schedule I and II drug traffickers from deducting business expenses) no longer applies to state-licensed medical operators. That’s hundreds of millions in newly deductible costs, flowing to the multi-state operators who’ve lobbied for exactly this outcome. The market noticed fast: the largest cannabis ETF hit its best levels of the year within weeks.
Then came the part that should bother anyone paying attention: a second, expedited hearing, June 29 through July 15 of this year, to decide whether Schedule III should extend to marijuana broadly, including recreational use. The DEA’s own attorney opened by stating plainly this wasn’t about recreational cannabis or legalization — it was narrowly about “currently accepted medical use.” Under the DEA administrator’s own rules, only parties opposed to rescheduling were credentialed to participate. No industry group. No patient advocates. Just opponents, cross-examining the government’s witnesses. Call it what it is: a kangaroo court, a verdict written before the first witness took the stand.
That’s not a process built to produce legalization. It’s built to produce a defensible record: a paper trail letting an administration claim it built a rigorous case for Schedule III while never drifting near ending prohibition, expunging records or closing the state-federal gap. The judge’s opinion won’t even be binding. The real decision sits with the DEA administrator, a political appointee, same as always.
Move cannabis to Schedule III, whenever DEA Administrator Terry Cole signs the final rule, and here’s what stays broken:
- Recreational cannabis remains federally illegal. Rescheduling doesn’t touch the prohibition outside the narrow medical/FDA lanes.
- The state-federal conflict doesn’t close. A grower in a legal state is still a federal criminal on paper. Banking and interstate commerce stay a patchwork.
- Past convictions don’t disappear. Nothing here expunges a record or releases anyone locked up for conduct that’s legal in dozens of states now.
- Small operators don’t get the win. The 280E relief favors operators with legal departments to absorb the compliance costs. The corner dispensary gets nothing.
The cannabis definition is also tightening in November 2026, folding hemp-derived products back under the marijuana umbrella, hitting small hemp businesses that had nothing to do with any of this.
Make no mistake: this isn’t an attack on one party or the other. It’s an attack on legislation without representation: the sneaky, underhanded way the government manufactures phantom policy and calls it progress.
Rescheduling isn’t a step toward rational policy. It’s a mechanism for extracting compliance costs out of a handful of connected operators while leaving the real injustice, criminalizing a plant less dangerous than what’s sold in every grocery store, fully intact for everyone without a lobbyist.
If the goal were honesty, the fix isn’t a schedule change. It’s federal descheduling: pull cannabis from the Controlled Substances Act entirely, expunge the convictions built on a lie the government’s own commission flagged in 1972, and let states and the market build something legitimate without a 50-year-old political decision still bolted to the frame.
Anything short of that isn’t reform. It’s the same authoritarian control dressed up as progress: a corporate penthouse built on a foundation everyone already knows is rotten.
Yet again, this is a disgraceful example of political theater. And the people are growing weary of it. The federal government stands on the precipice of making itself irrelevant through its own lack of representation. The people are growing tired of selfish impunity.
Corey Bergeron is a classically trained chef based in Weare with his wife and daughter.